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Verrucous papillary lesions (VPLs) of oral cavity are diagnostically challenging as they include a spectrum of benign, potentially
malignant, and frankly malignant lesions. A majority of the benign VPLs have viral aetiology and include commonly occurring
squamous papilloma alongwith verruca vulgaris, focal epithelial hyperplasia, and condyloma. Current understanding of potentially
malignant VPLs is perplexing and is primarily attributed to the use of confusing and unsatisfactory terminology. Clinically
and histologically oral verrucous hyperplasia, a potentially malignant disorder, resembles oral verrucous carcinoma and may be
indistinguishable from one another. The most reliable way to separate these entities on routine haematoxylin-eosin stained tissue
sections is to recognize the exophytic growth patterns of oral verrucous hyperplasia from the combined exophytic and endophytic
growth patterns associated with verrucous carcinoma. A review of the literature showed that there is a lot of confusion regarding the
current clinical and histopathological guidelines to diagnose this potentially malignant entity. The criteria elaborated by different
authors in establishing the diagnosis of oral verrucous hyperplasia are discussed in detail. A brief overview of the treatment
modalities adopted is also discussed.The need for establishing a clear understanding of this potentially malignant entity is stressed
as it may have far reaching implications on its management.
1. Introduction
Verrucous papillary lesions (VPLs) of the oral cavity are diag-
nostically challenging as they include a spectrum of benign,
potentially malignant, and frankly malignant lesions. A
majority of the benignVPLs have a viral aetiology and include
the more commonly occurring squamous papilloma along
with verruca vulgaris, focal epithelial hyperplasia, and condy-
loma [1]. Mucosal HPV types (HPV 6, 11, 13, 30, 32, 45, 52, 55,
59, 69, 72 and 73) have been isolated from these oral lesions
[2]. Histopathologically, these benign lesions do not demon-
strate any cellular atypia. It is sometimes difficult to distin-
guish these lesions, but clinical and certain histological fea-
tures facilitate their diagnosis [3, 4].
Benign VPLs with known aetiologic factors will not
be the focus of our discussion in this paper. Our current
understanding of potentially malignant VPLs is perplexing
and is primarily attributed to the use of confusing and unsat-
isfactory terminology.Thismay be best exemplified by verru-
cous hyperplasia, a potentially malignant disorder presenting
as a verrucous or exophytic growth characterized by keratosis
and/or varying grades of dysplasia [1]. Verrucous hyperplasia
is a histopathological entity with clinical features that may
be indistinguishable from a verrucous carcinoma [5]. The
pathologist may fail to convey to the clinician the potentially
malignant nature of verrucous hyperplasia due to the absence
of overt features of dysplasia, and the clinician may subse-
quently consider this as a benign condition.Thismay become
further established when reactive lesions such as inflamma-
tory papillary hyperplasia may also be casually diagnosed as
verrucous hyperplasia both clinically and histopathologically.
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2. Historical Background and Terminologies
The first ever documented evidence of a VPL dates back to
1941 when Fridell and Rosenthal reported a case of well-
differentiated squamous cell carcinoma of the oral cavity as
“papillary verrucoid carcinoma.” In 1948, Ackerman reported
a series of thirty one similar cases and coined the term “verru-
cous carcinoma” [6]. Ackerman is credited with the recogni-
tion of distinctive clinical and microscopic features of verru-
cous carcinoma that he considered to be a variant of squa-
mous cell carcinoma. A relatively high proportion of these
lesions tend to involve the buccal mucosa in tobacco chewers
[7]. These lesions are markedly exophytic and endophytic
with a tendency to erode the underlying tissues including
bone. Histomorphologic features include densely paraker-
atinized papillary surface, deep clefts in the epithelium,
blunt and voluminous rete ridges with little or no dysplastic
changes exhibiting a pushing border effect, and an intact
basement membrane [8]. Ever since its original description
within the oral cavity, there have been reports of similar
lesions occurring at other sites including the larynx, perianal
region, cervix, and glans penis [6].Many of these later reports
have remained true to the original description by Ackerman;
however, challenges exist in recognizing an optimal thera-
peutic approach, the incidence of recurrence, and frequency
of anaplastic transformation of verrucous carcinoma [9].
The general guidelines for the management of verrucous
carcinoma of the head and neck recognize surgical excision
as the primary treatment although the opinion is divided
among investigators on the role of radiotherapy alone or as an
adjunct to surgery as a treatmentmodality.The primary cause
of concern is reflected in the views that irradiation of verru-
cous carcinoma is less effective and more likely to result in a
recurrence with a more aggressive cancer through anaplastic
differentiation [10]. Carcinoma cuniculatum is a variant of
verrucous carcinoma and has also been described under an
array of confusing terminologies including inverted verru-
cous carcinoma and oral florid papillomatosis to name a few
[11].
Florid oral papillomatosis (FOP) is a rare disorder of the
oral cavity and lips, characterised by the presence of multiple
and multifocal papillomatous and verruciform growths that
form confluent plaques and vegetation. It was originally
recognized by Rock and Fisher [12] to describe multiple
papillary lesions involving the mouth and larynx [13]. Malig-
nant transformation has been reported in a subset of these
cases. Strangely enough different, terminologies such as ver-
rucous hyperplasia, verrucous leukoplakia, and papillomato-
sis mucosae carcinoides have been used synonymously to
describe this lesion [14]. The histopathologic feature of FOP
consisting of papillomatous and acanthotic as well as partially
keratinized epithelium with elongated rete ridges is distinct
from a verrucous carcinoma [14]. However, in the older
literature, this lesion is considered to be synonymous with
verrucous carcinoma [8].
Ackerman and McGavran [15] introduced the term “ver-
rucous hyperplasia” to describe a condition that closely
resembles verrucous carcinoma clinically and histologically.
A subsequent review by Adkins andMonsour [16] concluded
Figure 1: Photomicrograph of verrucous hyperplasia showing sharp
surface projections (original magnification 4x, H and E stain).
that an entity described as verrucous leukoplakia by many
authors may actually correspond to some forms of verrucous
hyperplasia [5]. Shear and Pindborg were the first to perform
a detailed clinical and histological analysis of verrucous
hyperplasias of the oral mucosa and unified previously used
terms such as verrucous leukoplakia under this distinct histo-
logic subset within the leukoplakia family of clinically identi-
fied lesions [17]. Clinically verrucous hyperplasias have been
classified into two variants, a sharp variety (Figure 1) compris-
ing long, narrow, and heavily keratinized verrucous processes
which appears white as result of heavy keratinization. This
entity may represent the form referred to as verrucous leuko-
plakia by many authors. The second clinical variant is a blunt
variety (Figures 2 and 3) consisting of verrucous processes
that are broader, flatter, and not heavily keratinized. In a
majority of cases, areas of homogeneous leukoplakia are an
integral component of the lesion and of the mucosa else-
where in the mouths of the same patients [5]. Histologically,
epithelial dysplasia is a prominent feature in verrucous hyper-
plasias and these lesions have been found to be juxtaposed
with verrucous carcinoma and squamous cell carcinoma in
a significant percentage of patients [17]. We propose that all
lesions whether they are of the blunt/sharp-type should be
relabelled as oral verrucous leukoplakia clinically. However,
confusion persists with regard to the blunt-type lesions which
are red, and it may not be possible to categorize them as ver-
rucous leukoplakia. It is recommended that all these lesions
should be diagnosed histologically as verrucous hyperplasia
based on the following criteria subject to a consensus. The
proposed histopathologic criteria for diagnosis of oral verru-
cous hyperplasia are as follows:
(a) long and narrow heavily keratinized verrucous pro-
cesses or broad and flat verrucous processes that are
less keratinized;
(b) absence of invasion of the hyperplastic epithelium
into the lamina propria as comparedwith the adjacent
normal mucosal epithelium;
(c) presence of cytologic/architectural features of dyspla-
sia.
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Figure 2: Photomicrograph of verrucous hyperplasia showing blunt
surface projections (original magnification 4x, H and E stain).
Oral verruciform leukoplakia is not firmly established in
the literature. This terminology was proposed by Wang et al.
to denote a subset of oral verrucous hyperplasias that strongly
resemble verrucous leukoplakia clinically [18].
3. Diagnostic Dilemmas
3.1. Clinical Spectrum of Oral Verrucous Hyperplasia. It has
been observed that leukoplakias may evolve through ver-
rucous hyperplasias, verrucous carcinomas, and eventually
squamous cell carcinomas [5]. A similar observation by
Slootweg and Muller led them to hypothesize that verrucous
hyperplasias and verrucous carcinomas represent a spectrum
of the same process which represents a ubiquitous premalig-
nant change in the whole oral mucous membrane [19]. The
characteristic histologic feature that distinguishes a verru-
cous carcinoma is the presence ofmicroscopic verrucous pro-
jections and endophytic epithelial extensions into the under-
lying lamina propria of which the latter are conspicuously
absent in verrucous hyperplasia [17]. Hansen et al. [20] in his
long term study on proliferative verrucous leukoplakia (PVL)
considered verrucous hyperplasia and verrucous carcinoma
as intermediate clinicopathological stages in its spectrum.
Thiswas subsequently confirmed by Batsakis et al. [21]. Origi-
nally described byHansen et al. [20], PVL is a recognized spe-
cific type of nonhomogeneous leukoplakia with an extremely
high propensity for malignant transformation [22]. Verru-
cous carcinomas exist within the histologic continuum rang-
ing from benign squamous hyperplastic lesions and prolifer-
ative verrucous lesions to invasive squamous cell carcinoma.
Distinguishing verrucous carcinoma from these similar
benign andmalignant processesmay be difficult.Thebelief by
earlier researchers that verrucous carcinomasmay evolve into
a conventional invasive squamous cell carcinomamay be due
to presence of small foci of squamous cell carcinoma in those
lesionswith dominant features of verrucous carcinoma. Some
investigators consider these verrucous squamous carcinomas
to be “hybrid” forms of verrucous carcinoma or a squamous
cell carcinoma with verrucoid features [10].We firmly believe
that addition of new terminologies may add to further con-
fusion, and therefore, the two entities—verrucous carcinoma
and squamous cell carcinoma—should remain independent.
Figure 3: Photomicrograph of verrucous hyperplasia showing blunt
surface projections (original magnification 4x, H and E stain).
It is strongly recommended that surgical specimens of verru-
cous carcinoma should be thoroughly sampled to avoidmiss-
ing an occult focus of conventional squamous cell carcinoma.
This will provide valuable information on management as
these two lesions have a different prognosis.
3.2. Clinical Variants of Oral Verrucous Hyperplasia. Wang
et al. [18] discussed in detail the clinicopathologic features
and behaviour of verrucous hyperplasia in sixty Taiwanese
patients. Contrary to the earlier accepted histological sub-
types as originally proposed by Shear and Pindborg, Wang
reclassified these lesions into (1) plaque-type and (2) mass-
type based on their histological features. The histologic
criteria for diagnosis were primarily epithelial hyperplasia
with parakeratosis or hyperkeratosis and a verrucous surface.
An absence of invasion of the hyperplastic epithelium into
the lamina propria as compared with the adjacent normal
mucosal epithelium was an additional important histologic
criterion for diagnosis. A surface keratin layer of >40 𝜇
thickness was accepted as a differentiator between the two
subtypes. Lesions exhibiting a verrucous surface with single
or multiple protruding masses of epithelial growth showing
minimal connective tissue cores and a surface keratin thick-
ness of <40 𝜇 were designated as the mass type. The plaque-
type lesions demonstrated a verrucous surface, epithelial
hyperplasia, and a surface keratin thickness of >40𝜇. Clin-
ically, the mass-type verrucous hyperplasia manifested as
single or multiple mass-like verrucous whitish pink lesions
while the plaque-type lesions appeared as whitish verrucous
plaques. Dysplasia was not a determinant in the diagnosis of
these lesions. However, in this study, the plaque-type lesions
exhibited a greater frequency of epithelial dysplasia [18].
Wang et al. remarked that they had difficulty in correlat-
ing the clinical and histopathological features of the plaque-
type lesions. The histopathological features of these lesions
conferred with their criteria but, a subsequent clinical reeval-
uation led them to reclassify these lesions as oral verruciform
leukoplakia. Thus, they concluded that the terminology oral
verrucous hyperplasia should be used to denote the mass-
type lesions both clinically and histologically. They also
suggested that the plaque-type lesions should be clinically
classified as oral verruciform leukoplakia and histologically
as verruciform hyperplasia [18].
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Our literature review from Taiwan also confirms that
there is a general consensus among the various authors there
regarding the clinical and histological characteristics of oral
verrucous hyperplasia which is in agreement with guidelines
proposed by Wang et al. as described earlier [23, 24]. There
does not seem to be any differences of opinion regarding the
potentially malignant nature of oral verrucous hyperplasias
and its association with high risk habits such as tobacco
and areca quid chewing and cigarette smoking. The primary
sites of involvement include the buccal mucosa, vestibular
mucosa, gingiva, and alveolar mucosa which are a reflection
of a direct cause and effect relationship associated with risk
habits [5, 18, 25, 26]. Clinically, they are manifested as white
to whitish pink lesions that can be attributed to variations in
the degree of keratinization.
The clinical appearance of these lesions has not generally
been well characterised as much emphasis has been laid on
the verrucous/exophytic nature of these lesions with little
attention being given to colour variation. Moreover, these
lesions are considered to be clinically indistinguishable from
verrucous carcinomas which are generally white or greyish
white in colour [8, 27, 28]. A significant association with
leukoplakia has been stressed in the literature. These areas of
homogeneous leukoplakia occur adjacent to oral verrucous
hyperplasia and histologically represent hyperkeratosis and
epithelial dysplasia. This as well as evidence from long term
follow up of patients with oral leukoplakia suggests that oral
verrucous hyperplasia actually represents a process in contin-
uum [5, 29]. Recognition of this feature is subdued inmany of
the reports from Taiwan where the lesions are primarily
described as either the mass or the plaque types. A combina-
tion type lesion with a peripheral plaque and a central mass
reported in the Taiwanese literature may be indicative of the
associated leukoplakia [18, 24]. This needs to be addressed
as reports from Taiwan may represent a subset of verrucous
hyperplasia where changes in the adjacent mucosa are less
pronounced. This has to be approached with caution bearing
in mind the concept of field cancerization where abnormal,
hyperplastic, and often atypical epithelium clinically visible as
leukoplakia or atrophic epitheliummay represent an area that
has been preconditioned by a carcinogen to develop into a
malignancy [30].
4. Histopathological Features of
Oral Verrucous Hyperplasia
Histologically, oral verrucous hyperplasia resembles oral
verrucous carcinoma and may be indistinguishable from one
another. The most reliable way to separate these entities on
routine haematoxylin-eosin stained tissue sections is to rec-
ognize the exophytic growth pattern of oral verrucous hyper-
plasia from the combined exophytic and endophytic growth
pattern associated with a verrucous carcinoma. In oral ver-
rucous carcinoma, the projections of neoplastic epithelium
are seen deep to the adjacent uninvolved epithelium,whereas,
in oral verrucous hyperplasia, they are seen only at the same
level as the adjacent epithelium. However, separation of these
lesions is often obscured by small biopsies, poorly orientated
specimens, and biopsies that fail to demonstrate the lesion
margins [27].The aforementioned histological features of oral
verrucous hyperplasia are unanimously recognized as a pre-
requisite for its diagnosis, whereas dysplasia is not. Epithelial
dysplasia with a propensity for moderate dysplasia has been
reported in amajority of cases of verrucous hyperplasia rang-
ing from 18 to 68% [5, 18, 26]. In a hospital based follow-up
study from Taiwan where oral verrucous hyperplasia is very
common, themalignant transformation rate was estimated at
20% in a cohort of forty-four male subjects with verrucous
hyperplasia. This was only second to epithelial dysplasia
which exhibited the highest rate of malignant transformation
of 24% [25].These estimatesmay further add to the confusion
as it has not been clearly stated whether cases classified as
epithelial dysplasia also included cases of verrucous hyper-
plasia with dysplasia in the first place.
5. Treatment of Oral Verrucous Hyperplasia
Poswillo is of the opinion that oral verrucous hyperplasia and
verrucous carcinoma should be managed similarly because
of the significant overlap in their clinicopathologic features
[31]. Many reports consider oral verrucous hyperplasia as a
potentially malignant disorder [18, 25]. However, it has not
been listed so by the WHO [32]. It is well established that
verrucous carcinoma is a low grademalignancy. It is also clear
that verrucous hyperplasia is a forerunner of verrucous car-
cinoma, and transition to the latter is quite consistent. Hence
there is an opinion that the two lesions should be managed
identically [33]. Verrucous carcinoma has been treated with
different modalities such as excision with or without radical
surgery, chemotherapy, radiation, or a combination of these
modalities [29]. Surgery is the most common treatment
modality, while the use of radiotherapy is controversial. The
conventional treatment of oral verrucous hyperplasia has
been total surgical excision. Recurrence and/or transforma-
tion of oral verrucous hyperplasia to either verrucous carci-
noma or conventional SCC have been reported after surgical
intervention. Shear and Pindborg reported recurrence in four
of their patients with lesions showing both verrucous hyper-
plasia and verrucous carcinoma [5].Thismay be subject to the
use of strict criteria for defining recurrence and differenti-
ating it from residual lesions. Wide surgical excision of the
primary verrucous lesion with adequate mucosal and soft-
tissue margin is necessary to avoid local recurrence [33].
6. Conclusion
It is evident from our discussion that clearer guidelines for
recognizing the clinical and histopathological features should
be established to diagnose oral verrucous hyperplasia. It is
proposed that both the sharp and the blunt varieties of oral
verrucous hyperplasia as originally recognized by Shear and
Pindborg and subsequently relabelled as the plaque-type and
mass-type lesions should be best diagnosed clinically as a
non-homogeneous leukoplakia or more specifically as verru-
cous leukoplakia [32]. Following histological evaluation, the
lesions may be further characterised as oral verrucous hyper-
plasia subject to a consensus.
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Recommendation
In this context, we recommend a consensus workshop to
determine an acceptable clinicopathological guideline for
recognizing oral verrucous hyperplasia. This will eliminate
the use of conflicting terminologies in the future that would
otherwise plague an overburdened vocabulary for character-
izing these lesions.
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